10860446 · Active · incorporated 9 years ago · Hertford
Biotech AI Biotech & Life Sciences Drug Discovery Series B+
DIOSynVax is a clinical-stage biotechnology company that develops next-generation vaccines using cutting-edge science and advanced computational design.
See the complete cap table with every shareholder, founder tags, dilution across 13 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.